DILYS CHEBE: Open Payments
NPI 1225733769 · GAINESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 23 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $356 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 9 | $199 |
| Lundbeck LLC | 3 | $90 |
| Bausch Health US, LLC | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Qelbree, REXULTI, APLENZIN, CAPLYTA, Auvelity, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
